|
Federal
Register Notices > Notices
of Registration - 2003 > Sigma Aldrich Research Biochemicals,
Inc.
[Federal Register: March 13, 2003 (Volume 68, Number
49)]
[Notices]
[Page 12104-12105]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13mr03-121]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Registration
By notice dated June 14, 2002, and published in the
Federal Register on June 28, 2002, (67 FR 43684), Sigma Aldrich Research
Biochemicals, Inc., Attn: Richard Milius, 1-3 Strathmore Road, Natick,
Massachusetts 01760, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| Aminorex (1585) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide (7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7392) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
[[Page 12105]]
| Drug |
Schedule |
| N-Hydroxy-3,4-methlenedioxyamphetamine
(7402) |
I |
|
3,4-Methylenedioxy-N-ethylamphetamine (7404) |
I |
|
3,4-Methylenedioxymethamphetamine (7405) |
I |
|
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) |
I |
|
Heroin (9200) |
I |
|
Normorphine (9313) |
I |
|
Amphetamine (1100) |
II |
|
Methamphetamine (1105) |
II |
|
Nabilone (7379) |
II |
|
Phenylcyclohexylamine (7460) |
II |
|
Phencyclidine (7471) |
II |
|
Cocaine (9041) |
II |
|
Codeine (9050) |
II |
|
Diprenorphine (9058) |
II |
|
Benzoylecgonine (9180) |
II |
|
Levomethorphan (9210) |
II |
|
Levorphanol (9220) |
II |
|
Meperidine (9230) |
II |
|
Metazocine (9240) |
II |
|
Methadone (9250) |
II |
|
Morphine (9300) |
II |
|
Thebaine (9333) |
II |
|
Carfentanil (9743) |
II |
|
Levo-alphacetylmethadol (LAAM) (9648) |
II |
|
Fentanyl (9801) |
II |
The firm plans to manufacture the listed controlled
substances for laboratory reference standards and neurochemicals.
DEA has considered the factors in Title 21, United
States Code, Section 823(a) and determined that the registration of Sigma
Aldrich Research Biochemicals, Inc. to manufacture the listed controlled
substances is consistent with the public interest at this time. DEA has
investigated Sigma Aldrich Research Biochemicals, Inc. on a regular basis
to ensure that the company's continued registration is consistent with the
public interest. These investigations have included inspection and testing
of the company's physical security systems, audits of the
company's records, verification of the company's compliance with state and
local laws, and a review of the company's background and history.
Therefore, pursuant to 21
U.S.C. 823 and 28 CFR 0.100 and 0.104, the
Deputy Assistant Administrator, Office of Diversion Control, hereby orders
that the application submitted by the above firm for registration as a
bulk manufacturer of the basic classes of controlled substances listed
above is granted.
Dated: February 28, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-6065 Filed 3-12-03; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
